Dissociating behavioral, autonomic, and neuroendocrine effects of androgen steroids in animal models

Methods Mol Biol. 2012:829:397-431. doi: 10.1007/978-1-61779-458-2_26.

Abstract

Developments in behavioral assessment, autonomic and/or baseline reactivity, psychopharmacology, and genetics, have contributed significantly to the assessment of performance-enhancing drugs in animal models. Particular classes of steroid hormones: androgenic steroids are of interest. Anecdotally, the performance enhancing effects of androgens are attributed to anabolic events. However, there is a discrepancy between anecdotal evidence and investigative data. While some androgen steroids may promote muscle growth (myogenesis), effects of androgens on performance enhancement are not always seen. Indeed, some effects of androgens on performance may be attributable to their psychological and cardiovascular effects. As such, we consider androgen effects in terms of their behavioral, autonomic, and neuroendocrine components. Techniques are discussed in this chapter, some of which are well established, while others have been more recently developed to study androgen action. Androgens may be considered for their positive impact, negative consequence, or psychotropic properties. Thus, this review aims to elucidate some of the effects and/or mechanisms of androgens on behavioral, autonomic, and/or neuroendocrine assessment that may underlie their controversial performance enhancing effects.

Publication types

  • Review

MeSH terms

  • Anabolic Agents / pharmacology
  • Androgen Receptor Antagonists / pharmacology
  • Androgens / pharmacology*
  • Animals
  • Autonomic Nervous System / drug effects*
  • Behavior, Animal / drug effects
  • Mice
  • Models, Animal
  • Muscles / drug effects
  • Neurosecretory Systems / drug effects*
  • Performance-Enhancing Substances / pharmacology*
  • Rats

Substances

  • Anabolic Agents
  • Androgen Receptor Antagonists
  • Androgens
  • Performance-Enhancing Substances